![Francesco Granata](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesco Granata
Director/Board Member at
Prismic Pharmaceuticals, Inc.
Net worth: 246 804 $ as of 30/06/2026
Profile
Francesco Granata is the founder of Micromega Ltd. Current positions include Director at Kyowa Kirin International Plc, Director at Italfarmaco SpA, Non-Executive Director at Helsinn Holding SA since 2018, Director at Prismic Pharmaceuticals, Inc., Director at Diadem SpA, Principal at Warburg Pincus International LLC since 2012, and General Partner at 3B Future Health Ventures SARL. Former roles include Non-Executive Chairman at Niox Group Plc from 2013 to 2019, Independent Non-Executive Director at Quanta Dialysis Technologies Ltd., Director at BSP Pharmaceuticals SpA, Managing Director at Pharmacia & Upjohn SpA, Director at Cell Therapy Ltd., Director at UTILITY therapeutics Ltd., Director at Helsinn Healthcare SA, President-Middle East & African Region at Pfizer Inc. in 2005, Group Vice President & President at Schering-Plough Corp., Executive VP-Global Commercial Operations at Biogen, Inc. from 2010 to 2011, Principal at Pharmacia Corp.
from 1999 to 2002, EVP-Global Commercial Operations at Biogen Idec New Ventures, Inc., Member at European Federation of Pharmaceutical Industries & Assns, Executive Vice President at Biogen Idec, Inc. (North Carolina), and Industrial Partner at FSI SGR SpA. Education includes a doctorate from the University of Pavia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NIOX GROUP PLC 0.07% | 01/05/2026 | 312,000 ( 0.07% ) | 246 804 $ | 30/06/2026 |
Francesco Granata active positions
| Companies | Position | Start |
|---|---|---|
Warburg Pincus International LLC
 Warburg Pincus International LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 05/03/2012 |
Prismic Pharmaceuticals, Inc.
 Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Director/Board Member | - |
Italfarmaco SpA
 Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director/Board Member | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Director/Board Member | - |
Diadem SpA
 Diadem SpA Miscellaneous Commercial ServicesCommercial Services Engages in predicting, diagnosis and drug development for alzheimer?s diseases | Director/Board Member | - |
Helsinn Holding SA
 Helsinn Holding SA Hospital/Nursing ManagementHealth Services Operates as a holding company whose subsidiaries provides cancer services | Director/Board Member | 01/10/2018 |
3B Future Health Ventures SARL
 3B Future Health Ventures SARL Investment ManagersFinance 3B Future Health Ventures Invests in companies located in Luxembourg, the United States, Japan and Israel. The firm targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage transactions with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director | Private Equity Investor | - |
Former positions of Francesco Granata
| Companies | Position | End |
|---|---|---|
Micromega Ltd.
 Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Founder | 19/06/2020 |
| NIOX GROUP PLC | Chairman | 05/12/2019 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Francesco Granata
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
24
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
University of Pavia
 University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Develops hemodialysis systems | Health Technology |
Helsinn Holding SA
Helsinn Holding SA Hospital/Nursing ManagementHealth Services Operates as a holding company whose subsidiaries provides cancer services | Health Services |
BSP Pharmaceuticals SpA
 BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures anticancer drugs | Health Technology |
Warburg Pincus International LLC
Warburg Pincus International LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
Pharmacia & Upjohn SpA | |
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Niox Group Plc
 Niox Group Plc Medical/Nursing ServicesHealth Services Develops immuno therapies to control immune system responses | Health Services |
3B Future Health Ventures SARL
3B Future Health Ventures SARL Investment ManagersFinance 3B Future Health Ventures Invests in companies located in Luxembourg, the United States, Japan and Israel. The firm targets companies operating in the fields of health technology and health services. It provides financing for seed and early stage transactions with an investment up to USD 12 million. It also makes follow on investment and take a seat on the board of director | Finance |
FSI SGR SpA
 FSI SGR SpA Investment ManagersFinance FSI invests in mid-market companies located in Italy. The firm targets companies operating in the fields of ICT and healthcare sector. It provides financing in the form of equity and debt for growth and buyout transactions with an investment size of EUR 60 - 250 million. | Finance |
Micromega Ltd.
Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products for the treatment of urinary tract infections | Health Technology |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Engages in predicting, diagnosis and drug development for alzheimer?s diseases | Commercial Services |
- Stock Market
- Insiders
- Francesco Granata
